Selective matrix metalloproteinase inhibitors

Patent

Description

The invention provides compounds, compositions, and methods for the treatment of diseases, disorders, or conditions that are modulated by matrix metalloproteinases (MMPs). The compounds can be selective MMP inhibitors, for example, selective inhibitors of MMP-2, MMP-9, and/or MMP-14. The disease, disorder, or condition can include, for example, stroke, neurological disorders, ophthalmological disorders, or wounds, such as chronic wounds or diabetic wounds.

Attributes

Attribute NameValues
Title
  • Selective matrix metalloproteinase inhibitors

Patent Number
  • US 9951035 B2

USPTO Link
Inventor
  • Mayland Chang

  • Shahriar Mobashery

Inventor From Local Institution
  • Mayland Chang

  • Shahriar Mobashery

Other Application
  • 15/469,010

Prior Publication Date
  • 2017-07-06

Prior Publication Number
  • US 20170190685 A1

Claims
  • 19

Cooperative Patent Classification codes
  • C07D 413/12 (20130101); C07D 331/02 (20130101); A61K 9/0014 (20130101); A61K 31/38 (20130101); A61K 31/4245 (20130101); C07D 303/34 (20130101)

International Patent Classification codes
  • C07D 331/02 (20060101); A61K 9/00 (20060101); A61K 31/38 (20060101); C07D 413/12 (20060101); C07D 303/34 (20060101); A61K 31/4245 (20060101)

Language
  • English

Date Issued
  • 2018-04-24

Publisher
  • U.S. Patent and Trademark Office

Assignee
  • University of Notre Dame Du Lac

Record Visibility and Access Public
Content License
  • All rights reserved

Departments and Units
Member of

Collections

Collections Featuring this Patent
Notre Dame Patents

Files

Please Note: You may encounter a delay before a download begins. Large or infrequently accessed files can take several minutes to retrieve from our archival storage system.